Campbell & Co Investment Adviser’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-54,229
| Closed | -$203K | – | 1119 |
|
|
2023
Q3 | $203K | Buy |
+54,229
| New | +$203K | 0.02% | 848 |
|
|
2022
Q4 | – | Sell |
-19,934
| Closed | -$192K | – | 794 |
|
|
2022
Q3 | $192K | Sell |
19,934
-7,030
| -26% | -$67.7K | 0.04% | 628 |
|
|
2022
Q2 | $195K | Buy |
+26,964
| New | +$195K | 0.05% | 608 |
|
|
2021
Q1 | – | Sell |
-12,206
| Closed | -$212K | – | 448 |
|
|
2020
Q4 | $212K | Sell |
12,206
-5,200
| -30% | -$90.3K | 0.13% | 349 |
|
|
2020
Q3 | $319K | Buy |
17,406
+4,300
| +33% | +$78.8K | 0.24% | 165 |
|
|
2020
Q2 | $234K | Buy |
+13,106
| New | +$234K | 0.3% | 166 |
|
|
2020
Q1 | – | Sell |
-18,666
| Closed | -$336K | – | 106 |
|
|
2019
Q4 | $336K | Sell |
18,666
-97
| -0.5% | -$1.75K | 0.1% | 374 |
|
|
2019
Q3 | $380K | Buy |
18,763
+3,731
| +25% | +$75.6K | 0.14% | 285 |
|
|
2019
Q2 | $332K | Buy |
+15,032
| New | +$332K | 0.15% | 268 |
|